Parabilis Medicines, Inc.

PBLS

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001657677

SEC filings (opens in a new tab)

Insider trades, last 90 days

2 buys · 0 sells

Bought $16.92M
Open-market purchases (P) and sales (S), counted by Form 4 filing.

View insider trades

13F holders, Q2 2026

79

+79 vs. Q1 2026
Total value $2.71B

View 13F holders

Superinvestors holding PBLS

0

None of the superinvestors held PBLS at the end of Q2 2026.

See all holders

Price chart

Chart by TradingView (opens in a new tab)

Latest insider trades

Open-market purchases and sales by PBLS insiders, newest first.

Insider trades
Filed (ET)	Trade date	Insider	Transaction	Shares	Avg price	Value	Shares after	Holding change	Filing
Jul 22, 20264:55 PM ET	Jul 20 – Jul 22, 2026	RA Capital Healthcare Fund LP and 4 othersDirector, 10% Owner	PPurchaseVoting Common Stock	+244.59K	$28.2901	+$6.92M	26.53M	+0.9%	SEC
Jun 29, 202610:41 AM ET	Jun 11, 2026	Soleus Capital, LLC and 8 others10% Owner	PPurchaseCommon Stock, par value $0.0001 per share	+500K	$20.00	+$10M	652K	+328.9%	SEC
Jun 16, 2026	Jun 12 – Jun 15, 2026	SEBULSKY ALANDirector	PPurchaseCommon Stock	+17.5K	$27.0605	+$473.56K	30K	+140.0%	SEC
Jun 15, 20266:57 PM ET	Jun 11, 2026	RA Capital Healthcare Fund LP and 4 othersDirector, 10% Owner	PPurchaseVoting Common Stock	+21.19M	$20.00	+$423.78M	2.65M	New position	SEC
Jun 15, 2026	Jun 11, 2026	SEBULSKY ALANDirector	PPurchaseCommon Stock	+12.5K	$20.00	+$250K	12.5K	New position	SEC

Top 5 13F holders, Q2 2026

The largest institutional positions in PBLS at the end of Q2 2026.

Institutions holding PBLS in Q2 2026
Institution	Shares	Value	% of portfolio	Change in shares	Action
RA CAPITAL MANAGEMENT, L.P.	28,933,371	$791.91M	6.88%	+28,933,371	New
FMR LLC	10,292,735	$281.71M	0.01%	+10,292,735	New
ARCH Venture Management, LLC	6,412,780	$175.52M	15.95%	+6,412,780	New
venBio Partners LLC	5,266,697	$144.15M	27.75%	+5,266,697	New
Alphabet Inc.	4,919,498	$134.65M	0.14%	+4,919,498	New